صورة الغلاف

Risk-sharing in the Pharmaceutical Industry The Case of Out-licensing /

The costs of developing a new drug have reached record levels in the pharmaceutical industry. As any failure of a new drug candidate can lead to significant losses, many pharmaceutical companies are looking for new approaches to reduce their exposure to R&D risks. In this context, the book deals...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Reepmeyer, Gerrit. (مؤلف, http://id.loc.gov/vocabulary/relators/aut)
مؤلف مشترك: SpringerLink (Online service)
التنسيق: الكتروني كتاب الكتروني
اللغة:English
منشور في: Heidelberg : Physica-Verlag HD : Imprint: Physica, 2006.
الطبعة:1st ed. 2006.
سلاسل:Contributions to Management Science,
الموضوعات:
Leadership.
Economics.
Management science.
Management.
Industrial management.
Business Strategy/Leadership.
Economics, general.
Innovation/Technology Management.
الوصول للمادة أونلاين:https://doi.org/10.1007/3-7908-1668-X
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
جدول المحتويات:
  • Key Issues in Managing Pharmaceutical Innovation
  • Risk-sharing as New Paradigm in Pharma R&D Collaborations
  • Case Studies on Risk-sharing in Pharma R&D Collaborations
  • Characteristics of Risk-sharing in Pharma R&D Collaborations
  • Theoretical Basis for Risk-sharing in Pharma R&D Collaborations
  • Managerial Recommendations for Risk-sharing in Pharma R&D Collaborations
  • Conclusion.

مواد مشابهة